Get monthly updates on metabolomics news and events

Microbiome

Virtual event

Transforming medicine with metabolomics

The countdown is on for the future of metabolomics

000

Day

:

00

Hrs

:

00

Min

:

00

Sec

Transforming medicine

with metabolomics

MxP® Quant 1000 – The new standard of excellence in metabolomics

Metabolomics is transforming biomedical research by providing deeper insights into metabolic pathways and microbiome-host interactions.

This webinar eplores the latest advancements in quantitative metabolomics profiling, highlighting how standardized assays and AI-driven data analysis are enabling researchers to study over 1,200 metabolites across 49 biochemical classes. Our expert speakers also discuss how these innovations are accelerating discoveries in health and disease research.

You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers. More Information

What to discover in this webinar

Functional-Microbiomics_Mikroben

Explore how metabolomics
is transforming medicine

Discover the new MxP® Quant 1000 assay for quantitative metabolomics profiling

Learn how to translate
metabolomics with instant insights

Learn how to translate
metabolomics results into meaning

Functional-Microbiomics_Mikroben

Explore how metabolomics
is transforming medicine

Discover the new MxP® Quant 1000 assay for quantitative metabolomics profiling

Speakers

Florence Raynaud Pharma Webinar

Alice Limonciel, Ph.D.

Chief Scientific Officer

biocrates life sciences
Innsbruck, Austria

 

Florence Raynaud Pharma Webinar

Markus Langsdorf, Ph.D.

Product Manager

biocrates life sciences
Innsbruck, Austria

 

Learn more about the upcoming MxP® Quant 1000 kit

Join us at our ASMS breakfast seminar and gain exclusive insight into the new MxP® Quant 1000 kit – an advanced metabolomics solution that standardizes the quantification of over 1,200 metabolites across 49 biochemical classes on multiple MS platforms.